Duke APOL1 Research Biorepository for Kidney Disease
This study is collecting biological samples (blood and urine) and medical information from adults to better understand kidney disease, especially in people of African ancestry. Researchers are interested in the ApoL1 gene, which is linked to kidney disease in individuals of recent African descent. The goal is to create a collection of samples that can be used to study why some people with ApoL1 mutations develop kidney failure and others don't. This research could help scientists understand the causes of kidney disease and potentially lead to new ways to prevent or treat it. The study aims to enroll 200 participants.
- Study design
- This is an observational study, meaning researchers will collect information and samples without giving any specific treatment. It plans to enroll 200 participants.
- What's involved
- You would provide biological samples (whole blood and urine) and relevant medical information. The duration of your participation is not specified.
- Compensation
- Not stated in the trial record.
- Follow-up
- The biorepository will be measured at 5 years, but individual participant follow-up is not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Duke APOL1 Research Biorepository
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Biorepository5 years
Number of biological samples collected and stored (whole blood and urine).